NASDAQ · Key Statistics

Insight Molecular Diagnostics Inc. (IMDX) Key Statistics

$2.83 NASDAQ: IMDX Market Cap $92.61M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Insight Molecular Diagnostics Inc. (IMDX), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-1.95
P/B ratioShare price divided by book value per share.	-5.12
P/S ratioMarket value divided by annual revenue.	58.20
PEG ratioP/E divided by the earnings growth rate.	-0.02
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-1.75
EV / RevenueEnterprise value against annual revenue.	49.14
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-51.55%
Free cash flow yieldFree cash flow as a percentage of market value.	-31.77%

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	11.17%
Operating marginRevenue left after operating costs.	-775.00%
Net marginRevenue left after every cost, including tax and interest.	-24.55%
Return on equityProfit as a percentage of shareholders’ equity.	271.76%
Return on assetsProfit as a percentage of total assets.	-167.64%
Return on capital employedOperating profit against the capital the business uses.	-223.06%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	2.00
Quick ratioThe same, excluding inventory.	1.98
Cash ratioCash alone against current liabilities.	1.00
Debt to equityTotal borrowings against shareholders’ equity.	-0.12
Debt to assetsTotal borrowings against total assets.	0.12
Interest coverageHow many times operating profit covers the interest bill.	-436.03

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-1.65
Book value per shareShareholders’ equity divided by shares outstanding.	$0.00
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$92.61M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$83.83M
EmployeesReported headcount.	46

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Insight Molecular Diagnostics Inc. (IMDX) statistics — frequently asked questions

What is Insight Molecular Diagnostics Inc.'s P/E ratio?

Insight Molecular Diagnostics Inc. (IMDX) trades on a price-to-earnings ratio of -1.95. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Insight Molecular Diagnostics Inc.'s return on equity?

Insight Molecular Diagnostics Inc. (IMDX) reports a return on equity of 271.76%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Insight Molecular Diagnostics Inc. carry?

Insight Molecular Diagnostics Inc. (IMDX) has a debt-to-equity ratio of -0.12, which compares total borrowings with shareholders' equity.

What is Insight Molecular Diagnostics Inc.'s profit margin?

Insight Molecular Diagnostics Inc. (IMDX) keeps -24.55% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.